geauxtohell
Choose your weapon.
I would like to know if a person who is immunodeficiency does she/ he still have to be vaccinated?
I would think it would depend on what kind of immunideficiency. Ask a doctor. Not an internet forum.
Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
I would like to know if a person who is immunodeficiency does she/ he still have to be vaccinated?
While these entities have made vaccines a requirement for some things and hope to make vaccines mandatory for mere existence, vaccines and antibiotics are nothing but willful poisoning. The best and safest way to prepare yourself against diseases and infections is to strengthen your body's natural defense system with proper nutrition and observe proper hygiene; such as frequent hand-wash. It is also wise to take ample Vitamin C (an effective anti-toxin) through foods high in Vitamin C or their natural supplements. Please, stay away from and say "NO!" to immunizations!
By the way, I believe Swine Flu and AIDS are the result of scientific experiment.
While these entities have made vaccines a requirement for some things and hope to make vaccines mandatory for mere existence, vaccines and antibiotics are nothing but willful poisoning. The best and safest way to prepare yourself against diseases and infections is to strengthen your body's natural defense system with proper nutrition and observe proper hygiene; such as frequent hand-wash. It is also wise to take ample Vitamin C (an effective anti-toxin) through foods high in Vitamin C or their natural supplements. Please, stay away from and say "NO!" to immunizations!
With the exception of the handwashing/hygiene comment: utter bullshit.
.
Avian flu shows signs of a resurgence, while a mutant strain - able to sidestep vaccines - could be spreading in Asia, the United Nations has warned. The variant appeared in Vietnam and China and its risk to humans cannot be predicted, veterinary officials said. Virus circulation in Vietnam threatens Thailand, Malaysia and Cambodia, where eight people have died after becoming infected this year, they warned. The World Health Organization says bird flu has killed 331 people since 2003. It has also killed or provoked the culling of more than 400m domestic poultry worldwide and caused an estimated $20bn (£12.2bn) of economic damage.
Wild birds
The virus had been eliminated from most of the 63 countries infected at its 2006 peak, which saw 4,000 outbreaks across the globe, but remains endemic in Bangladesh, China, Egypt, India, Indonesia and Vietnam. And the number of cases has been rising again since 2008, apparently because of migratory bird movements, said the UN's Food and Agriculture Organization (FAO) chief veterinary officer, Juan Lubroth.
"Wild birds may introduce the virus, but people's actions in poultry production and marketing spread it," he said. Avian flu has in the past two years appeared in poultry or wild birds in countries that had been virus-free for several years: Israel and the Palestinian Territories, Bulgaria, Romania, Nepal and Mongolia are among those recently affected.
Mr Lubroth said the new strain had infected most parts of northern and central Vietnam and could also pose a risk to Japan and the Korean peninsula.South Korea began culling hundreds of thousands of chickens and ducks in December last year after confirming its first cases since 2008.The FAO is calling for countries to adopt "heightened readiness and surveillance" against a resurgence of the virus.
BBC News - Bird flu fear as mutant strain hits China and Vietnam
The authors of two controversial bird flu studies have reportedly agreed to a US request to redact key details after a government advisory panel suggested the data could be used by terrorists. The papers show how a bird flu variant can pass easily between ferrets. Editors at the journals Science and Nature say they will not agree to the redactions until they are assured the data will be accessible to researchers. A spokesman for US health authorities said such a system was being prepared. At least one set of scientists have already rewritten their paper in light of the recommendation, Science reports.
Albert Osterhaus told Science his team "completely disagreed" with the recommendation of the panel, the the National Science Advisory Board for Biosecurity (NSABB). But Mr Osterhaus, who believes the information should be made widely available, said an editorial explaining his team's "genuflection" to the panel is a condition of the paper's publication in Science. A second research team at the University of Wisconsin, Madison is also reluctantly submitting a revised paper to Nature, a university spokesman confirmed to Science.
'Bona fide need'
While bird flu is deadly, its reach has been limited because it is not transmissible between humans. However, the flu virus was altered in the new studies to be passed easily between ferrets. Those mutations mean the flu would have "greater potential" to be contagious among humans, the NSABB said in a statement on Tuesday. The lab-created version, the board warned, represented an "extremely serious global public health threat". The NSABB recommended that the "general conclusions" be published but that final manuscripts not include details that "could enable replication of the experiments by those who would seek to do harm". Editors at Nature and Science said they wanted a clearer plan from the US government about how the potentially redacted data could be used by "all those responsible scientists who request it".
"Many scientists within the influenza community have a bona fide need to know the details of this research in order to protect the public, especially if they currently are working with related strains of the virus," Science editor-in-chief Bruce Alberts said. Mr Alberts said the magazine's response would be "heavily dependent upon the further steps taken by the US government to set forth a written, transparent plan" to ensure the information can be used by scientists who request it. "It is essential for public health that the full details of any scientific analysis of flu viruses be available to researchers," Dr Philip Campbell, editor of Nature said in a statement.
'Critical question'
The microbial culprit, norovirus, affects one in 15 Americans every year, causing sudden vomiting, diarrhea and stomach cramps that continue for a very unpleasant 24 to 48 hours, usually requiring no medical intervention. The U.S. Centers for Disease Control and Prevention in Atlanta says about half of cases of food poisoning are caused by norovirus, which has gained infamy as the cause of outbreaks on cruise ships, college campuses, nursing homes and other gathering places.
This month, at least 85 students fell ill at George Washington University in Washington, D.C., plus 186 at Rider University and about 100 at Princeton University, both in New Jersey. It also has hit hundreds of students in elementary, middle and high schools, and passengers on at least three cruise ships. "It's everywhere," says Jan Vinje of the CDC, who spoke about norovirus last week at a meeting of the American Association for the Advancement of Science. "Basically, January through April is high season for norovirus activity," he says, adding with a quip: "And now it's February Norovirus Appreciation Month."
Norovirus is estimated to affect more than 20 million Americans every year, causing about 800 deaths, usually a result of dehydration in the very young or the elderly. There is no vaccine and no treatment, and if you get infected by one strain, you can get walloped by another strain, or even re-infected a few months later by the one that got you first time around. People are contagious from the moment they feel ill to at least three days and possibly two weeks after they recover, the CDC says.
But there's hope. An antiviral medicine is in early development, and significant progress is being made toward a vaccine. Charles Arntzen of Arizona State University, who also spoke at the AAAS meeting, reports that a vaccine could be ready in a few years. LigoCyte Pharmaceuticals of Bozeman, Mont., is testing its nasal spray vaccine in human volunteers, and a second research group, coordinated through ASU, is moving toward human trials of a slightly different nasal vaccine. They're likely to require annual booster doses because of the potential for changes in the virus or for new strains to emerge, Arntzen says.
MORE
The vaccine is proving only 9 percent effective in those 65 and older against the harsh strain of the flu that is predominant this season, the Centers for Disease Control and Prevention said Thursday. Health officials are baffled as to why this is so. But the findings help explain why so many older people have been hospitalized with the flu this year. Despite the findings, the CDC stood by its recommendation that everyone over 6 months get flu shots, the elderly included, because some protection is better than none, and because those who are vaccinated and still get sick may suffer less severe symptoms. "Year in and year out, the vaccine is the best protection we have," said CDC flu expert Dr. Joseph Bresee.
Overall, across the age groups studied, the vaccine's effectiveness was found to be a moderate 56 percent, which means those who got a shot have a 56 percent lower chance of winding up at the doctor with the flu. That is somewhat worse than what has been seen in other years. For those 65 and older, the vaccine was only 27 percent effective against the three strains it is designed to protect against, the worst level in about a decade. It did a particularly poor job against the tough strain that is causing more than three-quarters of the illnesses this year.
It is well known that flu vaccine tends to protect younger people better than older ones. Elderly people have weaker immune systems that don't respond as well to flu shots, and they are more vulnerable to the illness and its complications, including pneumonia. But health officials said they don't know why this year's vaccine did so poorly in that age group. One theory, as yet unproven, is that older people's immune systems were accustomed to strains from the last two years and had more trouble switching gears to handle this year's different, harsh strain.
MORE
The vaccine was much better at protecting younger people.
Q: If the flu shot did such a poor job for older folks, why should they get it?
A: Government doctors and other health experts say it's better than nothing. And some scientists at the Centers for Disease Control and Prevention think it's possible that even this less effective vaccine may have lessened symptoms. But they don't know that for sure.
Q: How well did the vaccine work for younger age groups?
A: It offered "moderate" protection, the CDC says. For all ages who were vaccinated, there was a 56 percent chance of avoiding getting sick with the flu from any of the three strains in circulation. Generally a flu vaccine is considered pretty good if it's more than 60 percent effective.
Q: Why didn't the vaccine do a better job this year?
A: Scientists don't know. But it is much harder to make an effective vaccine against ever-shifting flu viruses than for diseases like measles, polio and diphtheria. Vaccines are generally 90 to 95 percent effective for those other diseases.
Q: Why was the shot especially weak at protecting older people?
A: Older, worn-out immune systems have a harder time responding to flu vaccines. Protection for those over 65 is considered good if they have a 30 or 40 percent lower chance of getting sick enough to see the doctor. This year, the vaccine provided about 27 percent protection against all three strains - but again, for the most dominant virus it was only 9 percent effective. On the upside, for people in their 50s and early 60s, protection against the worst virus was actually 50 percent.
Q: Can't we make a better vaccine?
A: Researchers are working on it. There is a higher-dose version for older people, but it's not clear how widely available it was and the study of vaccine effectiveness was too small to show whether it made a difference.
Source
Offering more protection to patients, the new quadrivalent vaccines provide a route to premium pricing that could improve margins and profits in a highly competitive market. Sanofi, GlaxoSmithKline and AstraZeneca all have products ready to tap the new opportunity, while Novartis is lagging behind its rivals. Until now, seasonal flu vaccines have only protected against three strains of flu - two strains of influenza A, which usually causes more cases and more severe illness, and one of influenza B, which is less common but also circulates in multiple forms.
The new vaccines include protection against a second strain of influenza B, which experts expect will prevent the vast majority of type B infections. But extra protection comes at a price. French drugmaker Sanofi, whose Sanofi Pasteur unit is the world's biggest supplier of flu vaccines, with sales of 884 million euros ($1.2 billion) in 2012, says it expects a premium of some 50 percent or more.
It reflects a determination by manufacturers to move up the value chain by developing more innovative and expensive vaccines, following the recent success of novel products such as HPV shots to protect girls against cervical cancer. Contracts struck with the U.S. Centers for Disease Control and Prevention (CDC) confirm a hefty price jump for the new four-strain flu vaccine, with GSK's quadrivalent Fluarix, for example, costing $12.03 per dose against $8.08 for the standard version, according to the agency's website.
Those price premiums may feed through to higher revenues and accelerated growth in a global flu vaccine market that research group Datamonitor Healthcare estimates at around $3.7 billion a year. Over time, more and more shipped vaccine is likely to be switched to quadrivalent, so over a five-year period it could lift revenue growth from the low single digit to the mid-to-high single digit [percentage] range, said Alistair Campbell, an industry analyst at Berenberg Bank. Some U.S. doctors see a more rapid take-up, with Paul Offit, chief of infectious diseases at the Children's Hospital of Philadelphia, predicting that only four-strain vaccines will be available within two years.
url=http://www.voanews.com/content/new-flu-vaccines-offer-more-protection-and-more-profits/1753288.html]Price Slide[/url]
Vaccines...another way for the criminal pharmaceutical machine to make more money off of people who don't need them and in some cases end up having a terrible reaction and in some cases death from them. This has just gotten out of hand, and I wish someone would put a stop to it. No wonder we have so many autistic children now and teenage girls getting sick and debilitated from Gardasil.